Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation

Stopped Recent improvements in clinical practice have reduced the apparent incidence of AMR in renal transplantation.

Conditions

• Graft Rejection
• Kidney Transplantation

Interventions

• PROCEDURE: plasmapheresis and IVIG
• DRUG: recombinant C1 inhibitor

Sponsor

Pharming Technologies B.V.

Collaborators

• [object Object]